Fig. 5
From: The hsa-miR-181a-5p reduces oxidation resistance by controlling SECISBP2 in osteoarthritis
The expression of hsa-miRNA-181a-5p, SBP2 and selenoproteins in peripheral blood. a The expression of hsa-miRNA-181a-5p in the peripheral blood of healthy controls and OA patients. (n = 19, 20). b The expression of SBP2 in the peripheral blood of healthy controls and OA patients. (n = 20, 20). c The expression of GPX1 in the peripheral blood of healthy controls and OA patients. (n = 20, 20). d The expression of SELS in the peripheral blood of healthy controls and OA patients. (n = 20, 19). The data are expressed as the mean ± SEM; *, ** and *** indicate P < 0.05, 0.01 and 0.001, respectively